Newsletter #1
- Dependence of Hypothalamic Obesity on Insulin, the Pituitary and the Adrenal
Gland.
- Hypothalamic obesity.
The autonomic hypothesis and the lateral hypothalamus.
- Autonomic Unbalance
and the Metabolic Syndrome: Hypothesis: The Unbalanced Autonomic Nervous
System Causes the Symptoms of the Metabolic Syndrome.
- Leptin and Androgens
in Male Obesity: Evidence for Leptin Contribution to Reduced Androgen
Levels.
- Chorionic Gonadotropin
in Obesity Further Clinical Observations.
- Bioavailability of hCG
after intramuscular or subcutaneous injection in obese and non-obese
women.
- Up-Regulation of
Placental Leptin by Human Chorionic Gonadotropin.
- In vitro effects of
chorionic gonadotropin hormone on human adipose development.
Newsletter #2
- Commercial preparations of hCG contain Beta-endorphin.
- Production of choriogonadotropin-like factor by a microorganism.
- Human chorionic gonadotropin-like substance in nonendocrine tissues of
normal subjects.
- Neuroanatomical correlates of hunger and satiation in humans using
positron emission tomography.
- Human chorionic gonodotropin-like material: presence in normal human
tissues.
Newsletter #3
- Do regional differences in adipocyte biology provide
new pathophysiological insights?
- Birth Weight, adult body composition, and subcutaneous fat distribution.
- Hypothalamic and pituitary dysfunction in obese males.
- Chorionic Gonadotropin in obesity. Further clinical observations.
- Grasa visceral y alteraciones metabólicas en hombres hipertensos.
- El uso de la gonadotrofina coriónica humana (hCG) por vía oral para el
tratamiento de la obesidad: estudio a doble ciego.
Alteraciones en el eje hipotálamo-tejido adiposo y su relación con el riesgo
para la aterosclerosis coronaria.
- Etiopatogenia de la obesidad.
Newsletter #4
- hCG and The State Board of Medical Examiners.
- In vitro effects of chorionic gonadotropin hormone on human adipose
development.
- Bioavailability of hCG after intramuscular or subcutaneous injection in
obese and non- obese women.
- The Diencephalon or Hypothalamus.
- Altered Hypothalamic Function in Response to Glucose Ingestion in Obese
Humans.
- Functional MRI of human hypothalamic responses following glucose ingestion.
- Functional magnetic resonance imaging of human hypothalamic responses to
sweet taste and calories.
- Leptina. Hormona de la Obesidad.
- Alteraciones en la conducta y en la alimentación por lesión en el núcleo
ventromedial del hipotálamo.
- Alteraciones neuroendocrinas en la obesidad.
- Modificación de los niveles de gonadotropinas hipofisiarias según el
índice de masa corporal y la distribución del tejido adiposo, en mujeres
posmenopáusicas que reciben distintos tipos de terapia hormonal de
reemplazo.
- Regulación de la ingesta y de la homeostasis energética.
- El uso de la Gonadotrofina Coriónica Humana (hCG) por vía oral para el
tratamiento de la obesidad.
Newsletter #5
- Alternative uses of hCG: Kaposi sarcoma.
- Metabolic effects of hCG in adipose tissue metabolism. The action of hCG
in adipose tissue metabolism.
- Widespread distribution of hCG in normal human tissues: the safety of hCG.
- Widespread distribution of hCG in Nature: the safety of hCG.
Newsletter #6
- Chorionic Gonadotrophin in the Treatment of Obese Women.
- Chorionic Gonadotrophin in the Treatment of Obesity.
- Altered Hypothalamic Function in Response to Glucose Ingestion in Obese
Humans.
- Effect of Human Chorionic Gonadotropin on Blood Free Fatty Acids, Glucose
and on the Release of Free Fatty Acids from Subcutaneous adipose tissue in
various Groups of Newborns and Adults.
Newletter #7
- Overweight or Overfat?
- Physical activity compliance: differences between overweight/obese and
normal-weight adults.
- Utility of an Oral Presentation of HCG (Human Choriogonadotropin) for the
Management of Obesity: A Double Blind Study.
- Controversies in plastic surgery: suction-assisted lipectomy (SAL) and the
hCG (human chorionic gonadotropin) protocol for obesity treatment.
- Aspectos neuroendocrinos de la obesidad.
- Etiopatogenia de la obesidad.
- Clasificación del sobrepeso y la obesidad.
- El uso de la Gonadotrofina Coriónica Humana (hCG) por vía oral para el
tratamiento de la obesidad: un estudio a doble ciego.
